Basal cell carcinoma pathophysiology

Jump to navigation Jump to search

Basal cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Basal Cell Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Basal cell carcinoma pathophysiology On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Basal cell carcinoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Basal cell carcinoma pathophysiology

CDC on Basal cell carcinoma pathophysiology

Basal cell carcinoma pathophysiology in the news

Blogs on Basal cell carcinoma pathophysiology

Directions to Hospitals Treating Basal cell carcinoma

Risk calculators and risk factors for Basal cell carcinoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Shivali Marketkar, M.B.B.S. [2]

Overview

Basal cell carcinomas develop in the basal cell layer of the skin. Cumulative DNA damage caused by chronic sunlight exposure results in DNA mutations that predispose to the development of basal cell carcinoma. On gross pathology, basal cell carcinoma lesions may demonstrate pearly pink nodules with telangiectasias, rolled borders, and central crusting with or without an ulcerating lesion (rodent ulcer). On microscopic analysis, peripheral palisading nuclei are characteristic.

Pathophysiology

Genetics

  • A number of aberrations involving the sonic hedgehog signaling pathway(SHH) are noted[1][2]
  • The majority of mutations in sporadic basal cell carcinoma and basal cell nevus syndrome(BCNS) patients occur in PTCH1 gene, a protein that inhibits Smoothened gene(SMO)
  • The second most common mutation in sporadic basal cell carcinoma and basal cell nevus syndrome(BCNS) patients are gain-of-function mutations of the Smoothened gene(SMO)
  • Loss of PTCH1 results in the failure of Smoothened inhibition, subsecuently leading to increases in GLI1 levels, changes in transcription, and subsequent tumorigenesis

Enviromental Exposure

  • Basal cell carcinomas develop in the basal cell layer of the skin
  • Cumulative DNA damage caused by chronic sunlight exposure results in DNA mutations that predispose to the development of basal cell carcinoma
  • While DNA repair eliminates most UV-induced damage, not all cross-links are excised, which eventually results in mutations
  • Apart from the mutagenesis, sunlight depresses the local immune system, possibly decreasing immune surveillance for new tumor cells

Gross Pathology








The image above depicts basal cell carcinoma in a 75 year old male. The following features are characteristic on gross pathology:

  • Pearly pink nodules
  • Telangiectasias
  • Rolled borders
  • Central crusting
  • Ulcerating lesion (rodent ulcer)

Microscopic Pathology

Shown below is a classic micrograph of basal cell carcinoma(H&E stain).The following features are characteristic:

  • Peripheral palisading nuclei
  • Myxoid stroma
  • Artefactual clefting








Shown below is the image of nodular variant of Basal cell carcinoma








Video

{{#ev:youtube|JnJXrFnvOKs}}

References

  1. Mohan SV, Chang AL (2014). "Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations". Curr Dermatol Rep. 3: 40–45. doi:10.1007/s13671-014-0069-y. PMC 3931971. PMID 24587976.
  2. Pellegrini C, Maturo MG, Di Nardo L, Ciciarelli V, Gutiérrez García-Rodrigo C, Fargnoli MC (November 2017). "Understanding the Molecular Genetics of Basal Cell Carcinoma". Int J Mol Sci. 18 (11). doi:10.3390/ijms18112485. PMC 5713451. PMID 29165358.


Template:WikiDoc Sources